BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2002
View Archived Issues
David Pharmaceuticals changes name, advances cognitive compounds
Read More
Leptin gene therapy in rats fed a high-fat diet
Read More
The novel spin trap agent NXY-059 improves safety profile of tPA
Read More
Sevelamer prevents progressive coronary and aortic calcification in hemodialysis patients
Read More
Pharmacia submits NDA for eplerenone in Japan
Read More
NEO-339 improves attention deficits, learning and memory in animals
Read More
Schering AG acquires MAP Medical Technologies
Read More
ETC-642 phase I results consistent with preclinical studies
Read More
Millennium discontinues oral MLN-977 program
Read More
NitroMed presents novel CINOD that compares favorably with naproxen
Read More
Retinal neuroprotective effects demonstrated for (-)-MR-22 and flunarizine in rat model
Read More
Effects of S-23478 characterized in rat models, discussed at scientific meetings
Read More
PRO-542 active in all primary target cells, particularly effective in treatment-experienced patients
Read More
Antinociceptive effects of a selective NMDA NR2B subunit antagonist
Read More
SR-140333 effective in rat model of cutaneous inflammatory pain
Read More
Janssen presents novel MTP inhibitors and their use in lipoprotein disorders
Read More
New vitamin D analogues for skin disorders emerge from Roche R&D
Read More
Celltech identifies new inhibitors of LFA-1/ICAM-1 interaction
Read More
Selective alpha4 integrin inhibitors in early development at Celltech R&D
Read More
Fumagillin derivatives and their use in angiogenesis disorders
Read More
New antifungal compound isolated from Pseudallescheria cultures at Yamanouchi
Read More
Researchers at GSK describe new 5-HT6 ligands for depression, anxiety, etc.
Read More
FDA grants priority review for Pegasys combination treatment
Read More
Amgen completes acquisition of Immunex
Read More
Telik exercises option to develop compounds from Arizona Cancer Center collaboration
Read More
GTC Biotherapeutics completes rhATIII study
Read More